Full-Time

Principal Scientist

In Vivo Pharmacology

Confirmed live in the last 24 hours

MSD

MSD

Compensation Overview

$167.7k - $263.9kAnnually

+ Bonus + Long Term Incentive

Senior, Expert

H1B Sponsorship Available

San Bruno, CA, USA

Hybrid work model requiring three days in-office per week.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Requirements
  • Ph.D. in biology, pharmacology, metabolism, immunology or related discipline and relevant industry experience
  • A minimum of 10 years of drug discovery experience at a biotech or pharmaceutical setting in obesity, dysmetabolism, diabetes and cardiovascular complications, with a proven track record substantiated by peer-reviewed publications and/or patents
  • A solid understanding of cardiometabolic disease pathogenesis and extensive experience in developing relevant in vivo models including both small and large animals
  • Experience leading discovery teams, overseeing in vivo strategy, setting project priorities, and managing resources
  • A robust understanding of preclinical drug discovery and clinical development
  • An excellent track record of providing mentorship to direct reports and influencing peers
  • The ability to communicate effectively with and relate to a broad range of stakeholders, including senior leaders, peers, direct reports, partners, and external collaborators
Responsibilities
  • Develop and support in vivo pharmacology strategies for obesity, immuno-metabolic, and cardiovascular diseases to enable a robust drug discovery pipeline
  • Lead translational model development and implementation to support target engagement, pharmacodynamics, or efficacy studies
  • Serve as a core member in matrixed project teams and governance committees to drive in vivo pharmacology strategy and provide scientific/technical leadership
  • Ensure high-quality data generation, analysis, and reporting to project teams, governance committees, and regulatory agencies, and manage key timelines and milestones
  • Lead and develop a group of PhD and non-PhD researchers, drive scientific innovation, and champion new enabling technologies to enhance functional capability and productivity
  • Monitor emerging biology, biomarker, as well as basic & clinical research in cardiometabolic disorders to influence portfolio development strategy
  • Collaborate extensively across our company's network and with external partners to drive pipeline progression toward key milestones

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A